Ad is loading...
MENU
CRNX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Crinetics Pharmaceuticals (CRNX) Ownership - Who owns Crinetics Pharmaceuticals?
Industry: @Pharmaceuticals Major
Profile
Industry
Pharmaceuticals Major
Address
6055 Lusk Boulevard
Phone
+1 858 450-6464
Employees
290
Web
https://www.crinetics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
5.12B
P/E Ratio
N/A
Total Cash
862.67M
Projected Growth
N/A
Total Debt
52.54M
Revenue
1.04M
Risk (Beta)
-0.14
Dividend Yield
N/A
Total Cash/Share
9.30
Total Debt/Equity
N/A
Revenue/Share
0.01 USD as % of share price
Fundamentals
CRNX
Capitalization
5.12B
P/E Ratio
N/A
Risk (Beta)
-0.14
Dividend Yield
N/A
Total Cash
863M
Total Cash/Share
9.30
Total Debt
52.5M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.01%
Revenue
1.04M
ROE
N/A
Book Value
833M
P/B Ratio
6.24
Cash Flow
N/A
Earnings
-3.7
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1.7B
Current Ratio
16.38
Current Revenue Per Employee
1900.00
Dividends Per Share - Security
N/A
EBITDA
-304.51M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-35.20
Shares Held By Institutions
6.44B
Shares Outstanding - Current
92.7M
Total Liabilities
104M
Total Volume MTD
N/A
Value
-1
Gain YTD
57.589
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of therapeutics for endocrine-related diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
6055 Lusk Boulevard
Phone
+1 858 450-6464
Employees
290
Web
https://www.crinetics.com